Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T18:25:59.712Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of calcium and magnesium pretreatment on hyperkalaemic cardiac arrest in rats

Published online by Cambridge University Press:  12 July 2005

M. W. Hollmann ,
D. Strümper ,
V. A. Salmons ,
J. M. Washington  and
M. E. Durieux
M. W. Hollmann
Affiliation:
University of Virginia, Department of Anesthesiology, Charlottesville, VA, USA University of Heidelberg, Department of Anesthesiology, Heidelberg, Germany
D. Strümper
Affiliation:
University Hospital Maastricht, Department of Anesthesiology, Maastricht, The Netherlands University of Munster, Department of Anesthesiology, Munster, Germany
V. A. Salmons
Affiliation:
University of Virginia, Department of Anesthesiology, Charlottesville, VA, USA Anesthesia Associates of Lancaster, Lancaster, PA, USA
J. M. Washington
Affiliation:
University of Virginia, Department of Anesthesiology, Charlottesville, VA, USA
M. E. Durieux
Affiliation:
University of Virginia, Department of Anesthesiology, Charlottesville, VA, USA University Hospital Maastricht, Department of Anesthesiology, Maastricht, The Netherlands
Get access

Abstract

Summary

Background and objective: Administration of calcium safely and effectively reverses many of the electrophysiological actions of hyperkalaemia, but it has not been studied for pretreatment. Based on cellular studies, magnesium also has been suggested to prevent the effects of potassium on the heart. As their mechanisms of action differ, a combination of these drugs might have a synergistic protective action. Both compounds are inexpensive and can be administered safely in modest doses. We investigated whether magnesium, calcium or their combination could protect against hyperkalaemic cardiac arrest.

Methods: Twenty-four adult rats were anaesthetized with halothane and randomly pretreated with CaCl2 15 mg kg−1, MgSO4 30 mg kg−1, CaCl2 7.5 mg kg−1 + MgSO4 15 mg kg−1 or physiological saline. Potassium (0.01 mmol kg−1 h−1) was infused. The times to the first dysrhythmia, mean arterial pressure decrease to <40% of baseline and cardiovascular collapse were measured.

Results: Serum potassium concentrations increased to similar values in all groups (to 12.0 ± 0.2 mmol L−1 at the time of collapse). No differences in survival times were observed between groups. There was a trend for respiratory values to be better in the group receiving magnesium.

Conclusions: Pretreatment with magnesium, calcium or a combination of both did not influence the time to cardiovascular collapse, and is therefore – at least in our model – not of any benefit in preventing hyperkalaemic cardiac arrest.

Keywords

CARDIOVASCULAR PHYSIOLOGY, ventricular functionHOMEOSTASIS, electrolyte balanceVERTEBRATES, rats, Sprague–Dawley
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 20 , Issue 8 , September 2003 , pp. 606 - 611
Copyright
2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Schulte-Sasse U, Eberlein HJ, Schmucker I, Underwood D, Wolbert R. Should the use of succinylcholine in pediatric anesthesia be re-evaluated? Anaesthesiol Reanim 1993; 18: 13–19.Google Scholar
Thapa S, Brull SJ. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg 2000; 91: 237–241.Google Scholar
MacLennan N, Heimbach DM, Cullen BF. Anesthesia for major thermal injury. Anesthesiology 1998; 89: 749–770.Google Scholar
Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 1975; 43: 89–99.Google Scholar
Bisogno JL, Langley A, von Dreele MM. Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: a prospective, dose–response study. Crit Care Med 1994; 22: 697–704.Google Scholar
Kraft LF, Katholi RE, Woods WT, James TN. Attenuation by magnesium of the electrophysiologic effects of hyperkalemia on human and canine heart cells. Am J Cardiol 1980; 45: 1189–1195.Google Scholar
Ifune CK, Steinbach JH. Voltage-dependent block by magnesium of neuronal nicotinic acetylcholine receptor channels in rat phaeochromocytoma cells. J Physiol 1991; 443: 683–701.Google Scholar
Levinsky NG. Management of emergencies. VI. Hyperkalemia. N Engl J Med 1966; 274: 1076–1077.Google Scholar
Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158: 917–924.Google Scholar
Greenberg A. Hyperkalemia: treatment options. Semin Nephrol 1998; 18: 46–57.Google Scholar
Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of development and hemodynamic effects of acute hyperkalemia in halothane-anesthetized dogs: effects of calcium therapy. Anesthesiology 1984; 60: 435–439.Google Scholar
Kunis CL, Lowenstein J. The emergency treatment of hyperkalemia. Med Clin North Am 1981; 65: 165–176.Google Scholar
Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res 1998; 11: 43–56.Google Scholar
Gomez MN. Magnesium and cardiovascular disease. Anesthesiology 1998; 89: 222–240.Google Scholar
Rochester DF, Arora NS. Respiratory muscle failure. Med Clin North Am 1983; 67: 573–597.Google Scholar
Johnson D, Gallagher C, Cavanaugh M, Yip R, Mayers I. The lack of effect of routine magnesium administration on respiratory function in mechanically ventilated patients. Chest 1993; 104: 536–541.Google Scholar
Gluckman TJ, Corbridge T. Management of respiratory failure in patients with asthma. Curr Opin Pulm Med 2000; 6: 79–85.Google Scholar
Mangat HS, D'Souza GA, Jacob MS. Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J 1998; 12: 341–344.Google Scholar
Mills R, Leadbeater M, Ravalia A. Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic. Anaesthesia 1997; 52: 782–785.Google Scholar
Downey P, Cox R. Update on the management of status asthmaticus. Curr Opin Pediatr 1996; 8: 226–233.Google Scholar
Sydow M, Crozier TA, Zielmann S, Radke J, Burchadi H. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 1993; 19: 467–471.Google Scholar